Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells

• Published in: Xenobiotica Vol. 20; no. 4; p. 435
• Main Authors: Doostdar, H, Demoz, A, Burke, M D, Melvin, W T, Grant, M H
• Format: Journal Article
• Language: English
• Published: England 1990
• Subjects: Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - pathology; Cell Division; Cytochrome Reductases - metabolism; Enzymes - metabolism; Epoxide Hydrolases - metabolism; Glucuronosyltransferase - metabolism; Glutathione - metabolism; Glutathione Transferase - metabolism; Humans; Kinetics; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Mixed Function Oxygenases - metabolism; Tumor Cells, Cultured - metabolism; Tumor Cells, Cultured - pathology; Xenobiotics - metabolism
• ISSN: 0049-8254
• DOI: 10.3109/00498259009046859

1. The activities of several drug-metabolizing enzymes change during the growth cycle (exponential growth to confluence) of Hep G2 cells in culture. As the rate of cell growth slowed down (days 7 to 10 after passage) the activities of ethoxy- and methoxy-resorufin O-dealkylase and of NADPH cytochrome c- and NADH cytochrome b5-reductase increased. In contrast, the O-dealkylations of pentoxy- and benzyloxy-resorufin did not change significantly during culture. 2. UDP-glucuronyltransferase activities also showed substrate-dependent alterations with time in culture. In contrast, glutathione-S-transferase activity remained constant despite a decline in the intracellular reduced glutathione content. 3. Epoxide hydrolase activity altered throughout time in culture, with an initial decrease in activity followed by a marked increase between days 7 and 10 after passage. 4. These results indicate the importance of standardizing the protocol with regard to the timing of experiments within the growth period of the cells when using hepatoma cell lines for assessing the metabolism and cytotoxicity of chemicals.